References
- Paterson DL, Bonomo RA. Extended-Spectrum beta-lacta-mases: a clinical update. Clin Microbiol Rev 2005; 18: 657–686.
- Hyle EP, Lipworth AD, Zaoutis TE et al. Risk factors for in-creasing multidrug resistance among extended-spectrum beta-lac-tamase-producing Escherichia coli and Klebsiella species. Clin Infect Dis 2005; 40: 1317–1324.
- Tumbarello M, Spanu T, Sanguinetti M et al. Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epi-demiology and clinical outcome. Antimicrob Agents Chemother 2006; 50: 498–504.
- Lautenbach E, Strom BL, Bilker WB, Patel JB, Edelstein PH, Fishman NO. Epidemiological investigation of fluoro-quinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis 2001; 33: 1288–1294.
- Paterson DL, Mulazimoglu L, CaseIlas JM et al. Epidemi-ology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis 2000; 30: 473–478.
- Tolun V, Kucukbasmaci O, Torumkuney-Akbulut D, Catal C, Ang-Kucuker M, Ang 0. Relationship between ciprofloxacin resistance and extended-spectrum beta-lactamase production in Escherichia coli and Klebsiella pneumoniae strains. Clin Mi-crobiol Infect 2004; 10: 70–83.
- Robert J, Cambau E, Grenet K et al. Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992-98. Clin Microbiol Infect 2001; 7: 553–561.
- Mammeri H, Van De Loo M, Poirel L, Martinez-Martinez L, Nordmann P. Emergence of plasmid-mediated quinolone re-sistance in Escherichia coli in Europe. Antimicrob Agents Chemother 2005; 49: 71–76.
- Corkill JE, Anson JJ, Hart CA. High prevalence of the plas-mid-mediated quinolone resistance determinant qnrA in mul-tidrug-resistant Enterobacteriaceae from blood cultures in Liverpool, UK. J Antimicrob Chemother 2005; 56: 1115–1117.
- Poirel L, Van De Loo M, Mammeri H, Nordmann P. As-sociation of plasmid-mediated quinolone resistance with ex- tended-spectrum beta-lactamase VEB-1. Antimicrob Agents Chemother 2005; 49: 3091-3094.
- Clinical and Laboratory Standards Institute (Formerly Na-tional Committee for Clinical Laboratory Standards).Perform-ance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement. M100-515. Wayne, PA: CLSI, 2005.
- Arslan H, Azap OK, Ergonul O, Timurkaynak F, on behalf of the Urinary tract infections in Turkey. Risk factors for ciprofloxacin resistance among Escherichia coil strains isolated from community-acquired urinary tract infections in Turkey. J Antimicrob Chemother 2005; 56: 914–918.
- Kahlmeter G, Menday P, Cars O. Non-hospital antimi-crobial usage and resistance in community acquired Escherichia coli urinary tract infection. J Antimicrob Chemother 2003; 52: 1005–1010.